These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21923586)

  • 1. Detectability of vasopressin in continuous venovenous hemodialysis effluent of patients with vasodilatory shock treated with exogenous arginine vasopressin.
    Bauer SR; Culver DA; Abraham S; Lam SW; Fissell WH; Wiedemann HP; Reddy AJ
    Pharmacotherapy; 2011 Sep; 31(9):857-62. PubMed ID: 21923586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma copeptin levels before and during exogenous arginine vasopressin infusion in patients with advanced vasodilatory shock.
    Torgersen C; Luckner G; Morgenthaler NG; Jochberger S; Schmittinger CA; Wenzel V; Hasibeder WR; Grander W; Dünser MW
    Minerva Anestesiol; 2010 Nov; 76(11):905-12. PubMed ID: 20386508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Lam SW; Bauer SR; Cha SS; Oyen LJ
    Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
    Dünser MW; Mayr AJ; Tür A; Pajk W; Barbara F; Knotzer H; Ulmer H; Hasibeder WR
    Crit Care Med; 2003 May; 31(5):1394-8. PubMed ID: 12771608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early continuous venovenous hemodialysis in dialysis-dependent patients after cardiac surgery: safety and efficacy.
    Nakasuji M; Nishi S; Nakasuji K; Hamaoka N; Ikeshita K; Asada A
    J Cardiothorac Vasc Anesth; 2007 Jun; 21(3):379-83. PubMed ID: 17544890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement.
    Argenziano M; Choudhri AF; Oz MC; Rose EA; Smith CR; Landry DW
    Circulation; 1997 Nov; 96(9 Suppl):II-286-90. PubMed ID: 9386112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous hemodiafiltration compared with conventional dialysis in critically ill patients with acute renal failure.
    Bellomo R; Boyce N
    ASAIO J; 1993; 39(3):M794-7. PubMed ID: 8268647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of vasodilatory shock: defining the role of arginine vasopressin.
    Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
    Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular autoregulation in critically ill patients during continuous hemodialysis.
    Schramm P; Closhen D; Wojciechowski J; Berres M; Klein KU; Bodenstein M; Werner C; Engelhard K
    Can J Anaesth; 2013 Jun; 60(6):564-9. PubMed ID: 23536386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond.
    Dünser MW; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):122-7. PubMed ID: 18443477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose vasopressin is not superior to norepinephrine in septic shock.
    Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
    Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin rescue for in-pediatric intensive care unit cardiopulmonary arrest refractory to initial epinephrine dosing: a prospective feasibility pilot trial.
    Carroll TG; Dimas VV; Raymond TT
    Pediatr Crit Care Med; 2012 May; 13(3):265-72. PubMed ID: 21926666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine vasopressin for the treatment of septic shock in adults.
    Bauer SR; Lam SW
    Pharmacotherapy; 2010 Oct; 30(10):1057-71. PubMed ID: 20874043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome.
    Luckner G; Dünser MW; Stadlbauer KH; Mayr VD; Jochberger S; Wenzel V; Ulmer H; Pajk W; Hasibeder WR; Friesenecker B; Knotzer H
    Crit Care; 2006; 10(2):R40. PubMed ID: 16542484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism.
    Arbeiter AK; Kranz B; Wingen AM; Bonzel KE; Dohna-Schwake C; Hanssler L; Neudorf U; Hoyer PF; Büscher R
    Nephrol Dial Transplant; 2010 Apr; 25(4):1257-65. PubMed ID: 19934086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.